Asymptomatic recurrence in patients with pulmonary embolism

To date, much of our knowledge about recurrent PE has come from clinical trials or registry studies in which symptomatic recurrence was a major endpoint, while asymptomatic recurrence is rarely reported. [...]current guidelines suggest treating patients with asymptomatic PE similarly to those with s...

Full description

Saved in:
Bibliographic Details
Published inChinese medical journal Vol. 137; no. 9; pp. 1118 - 1120
Main Authors Hu, Song, Wang, Lei, Tan, Jiangshan, Fang, Wei, Ma, Xinghong, Guo, Tingting, Gao, Xin, Wu, Yan, Zhou, Yuzi, Wang, Li, Hua, Lu
Format Journal Article
LanguageEnglish
Published China Lippincott Williams & Wilkins Ovid Technologies 05.05.2024
Lippincott Williams & Wilkins
Wolters Kluwer
Subjects
Aged
Anticoagulants
Asymptomatic
Blood clots
Correspondence
Drug dosages
Female
Humans
Male
Middle Aged
Nuclear medicine
Pulmonary arteries
Pulmonary Embolism - diagnosis
Pulmonary embolisms
Pulmonary hypertension
Recurrence
Thromboembolism
Thrombosis
Online AccessGet full text

Cover

More Information
Summary:To date, much of our knowledge about recurrent PE has come from clinical trials or registry studies in which symptomatic recurrence was a major endpoint, while asymptomatic recurrence is rarely reported. [...]current guidelines suggest treating patients with asymptomatic PE similarly to those with symptomatic PE,[1,2] but do not recommend routine follow-up of asymptomatic patients by imaging methods after PE diagnosis. [...]a significant difference in the distribution of pulmonary perfusion defects was observed at baseline. [...]we did not collect follow-up data for outcomes in the longer term, including death and the development of pulmonary hypertension, because this was not a study objective. [...]the present study indicated that some PE patients may experience asymptomatic recurrence, and these patients are easily ignored.
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ISSN:0366-6999
2542-5641
DOI:10.1097/CM9.0000000000003047